Results 281 to 290 of about 704,143 (399)

Mortality risk stratification for Takotsubo syndrome: Evaluating CRP measurement alongside the InterTAK prognostic score

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1427-1436, April 2025.
Abstract Background and objectives Initially described as a benign acute cardiomyopathy, Takotsubo syndrome has been linked to elevated mortality rates. Emerging evidence suggests that unresolved myocardial inflammation may contribute to this adverse prognosis.
Loïc Faucher   +12 more
wiley   +1 more source

Left atrial strain during stress echocardiography for the assessment of myocardial ischaemia. [PDF]

open access: yesUltrasound
Bonotto EH   +3 more
europepmc   +1 more source

Cilostazol in patients with heart failure and preserved ejection fraction—The CLIP‐HFpEF trial

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1437-1446, April 2025.
• Cilostazol is an oral PDE‐3 inhibitor that may have advantageous effects in heart failure with preserved ejection fraction (HFpEF). • Cilostazol significantly improved short‐term heart failure‐related health status scores (KCCQ‐12) and NT‐proBNP levels when compared to placebo.
Norman Aiad   +9 more
wiley   +1 more source

Cardiac Mass, Bacteremia, and Embolic Stroke. [PDF]

open access: yesJACC Case Rep
Kieu NT   +9 more
europepmc   +1 more source

The clinical use of stress echocardiography in non-ischaemic heart disease: recommendations from the European Association of Cardiovascular Imaging and the American Society of Echocardiography.

open access: yesEuropean Heart Journal-Cardiovascular Imaging, 2016
P. Lancellotti   +16 more
semanticscholar   +1 more source

Right ventricle to pulmonary artery coupling as a prognostic factor in tricuspid regurgitation: A systematic review

open access: yesESC Heart Failure, EarlyView.
The TAPSE/SPAP ratio is associated with worse prognosis in patients with significant tricuspid regurgitation and could indicate at‐risk patients. The exact cutoff value for RV‐PA uncoupling remains difficult to define and in available studies ranged from 0.26 to 0.49 mm/mmHg.
Adam Piasecki   +5 more
wiley   +1 more source

Early diagnostic value of novel biomarkers for breast cancer therapy‐related cardiac dysfunction

open access: yesESC Heart Failure, EarlyView.
Our meta‐analysis revealed significant post‐treatment increases in GDF‐15, CRP, MPO, and PLGF levels (Gal‐3 unchanged) among breast cancer patients. Only elevated MPO levels were significantly associated with an increased risk of cancer therapy‐related cardiac dysfunction (CTRCD).
Zhengwei Wang   +4 more
wiley   +1 more source

Early in‐hospital treatment of acute heart failure. Part 2 of the international expert opinion series on AHF management

open access: yesESC Heart Failure, EarlyView.
This state‐of‐the‐art review outlines a practical, evidence‐based framework for early acute heart failure management to address critical gaps in current guidance and improve early treatment outcomes. Key components include early identification of co‐existing conditions, bedside haemodynamic profiling, a structured diagnostic approach incorporating both
Anika S. Naidu   +22 more
wiley   +1 more source

Home - About - Disclaimer - Privacy